Microbiology diagnostic devices market seen reaching $11.53 billion by 2030

The Business Research Company says the global microbiology diagnostic devices and equipment market will rise from $6.43 billion in 2025 to $11.53 billion by 2030, driven by faster testing demand, lab automation and antimicrobial resistance monitoring. North America led the market in 2025, while a WHO cancer forecast underscores the broader diagnostic demand behind the growth.

Why it matters: - Microbiology diagnostic devices and equipment are used to detect infectious agents, support hospital testing and monitor patient health. - The market’s growth signals continued spending on laboratory automation, rapid diagnostics and point-of-care testing. - Rising demand matters for providers facing more infectious disease testing and more complex disease management needs.

What happened: - The Business Research Company released a market outlook on the microbiology diagnostic devices and equipment sector. - The market is projected to grow from $6.43 billion in 2025 to $7.5 billion in 2026. - The report forecasts the market will reach $11.53 billion by 2030. - The forecast implies a 16.6% CAGR from 2025 to 2026 and an 11.4% CAGR through 2030. - The report includes a free sample and the full market report.

The details: - The market’s recent expansion has been driven by healthcare infrastructure development, higher infectious disease rates, more hospital-based testing, advances in laboratory automation and wider access to microbiology consumables. - Microbiology diagnostic devices and equipment include microscopes, slides, test tubes, Petri dishes, liquid and solid growth media, inoculation loops, pipettes, pipette tips, incubators, autoclaves and laminar flow hoods. - Microscopes and flow hoods are permanent lab equipment, while pipette tips are consumables that are regularly replaced. - The report says future growth will come from rapid diagnostic testing, more investment in automated laboratory systems, broader use of molecular and microbiology techniques, stronger antimicrobial resistance detection and more point-of-care microbiology tools. - Key trends include automated microbiology analyzers, rapid pathogen detection, high-throughput instruments, advanced culture and identification methods and workflow automation. - North America was the largest regional market in 2025. - Asia-Pacific ranked second in 2025. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The biggest demand driver is not just infection testing. It is the wider clinical burden created by noncommunicable diseases, which often requires lab-based testing to identify infections and track patient status. - The report points to a shift from manual lab workflows toward faster, more automated systems that can handle higher test volumes. - WHO projected in February 2024 that global cancer diagnoses will exceed 35 million by 2050, up 77% from about 20 million in 2022, adding to the demand for diagnostic capacity.

What's next: - The report expects continued adoption of automation and molecular methods as labs seek faster turnaround times. - Market participants are likely to focus on antimicrobial resistance testing and point-of-care tools as testing needs broaden. - The 2026 report update adds TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics and updated graphics and tables. - The Business Research Company also highlighted expert contact information and social channels for follow-up.